The investigational opioid antagonist drug TD-1211 eased opioid-induced constipation for chronic pain patients compared with a placebo, researchers told a gastroenterology conference. The effect lasted for at least three weeks and the drug did not interfere with the pain medication.
Investigational drug helps opioid-induced constipation
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||